CMA
MRNA icon

Cedar Mountain Advisors’s Moderna MRNA Stock Holding History

Cedar Mountain Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13
Closed -$383 – 1181
2025
Q4 		$383 Hold
13
– – ﹤0.01% 637
2025
Q3 		$336 Hold
13
– – ﹤0.01% 629
2025
Q2 		$359 Hold
13
– – ﹤0.01% 341
2025
Q1 		$369 Hold
13
– – ﹤0.01% 328
2024
Q4 		$541 Sell
13
-60
-82% -$2.87K ﹤0.01% 348
2024
Q3 		$4.88K Sell
73
-10
-12% -$918 ﹤0.01% 249
2024
Q2 		$9.86K Hold
83
– – ﹤0.01% 190
2024
Q1 		$8.84K Buy
83
+10
+14% +$1.01K ﹤0.01% 194
2023
Q4 		$7.26K Hold
73
– – ﹤0.01% 199
2023
Q3 		$7.54K Buy
+73
New +$8.14K ﹤0.01% 191

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return